Patent · US Active

Proton-binding polymers for oral administration

US10391118B2 · kind B2 · utility

8Cited by

34References

46Claims

0Family size

Assignee

TRICIDA, INC. · US

Inventors

Gerrit Klaerner · Los Gatos, US
Eric Connor · Los Gatos, US
Randi K. GBUR · Brisbane, US
Matthew J. KADE · Berkeley, US
Paul H. KIERSTEAD · Oakland, US
Jerry M. Buysse · Los Altos, US
Michael J. Cope · Berkeley, US
Kalpesh Biyani · Fremont, US
Son H. NGUYEN · Milpitas, US
Scott M. TABAKMAN · Palo Alto, US

Key dates

Filing date	Jun 7, 2018
Grant date	Aug 27, 2019
Priority date	—
Expiry date	Jun 7, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T428/2982
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.